Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001178913-09-002261
Filing Date
2009-09-24
Accepted
2009-09-24 10:58:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 zk97287.htm SC 13D/A 16290
  Complete submission text file 0001178913-09-002261.txt   18420
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50118 | Film No.: 091083964
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1 AZRIELI CENTER, ROUND TOWER,38TH FLOOR TEL AVIV L3 67021
Business Address 1 AZRIELI CENTER, ROUND TOWER,38TH FLOOR TEL AVIV L3 67021 972-3-7188700
Marathon Investments Ltd. (Filed by) CIK: 0001385788 (see all company filings)

EIN.: 000000000
Type: SC 13D/A